This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Thaete, L. G. Articles by Caplan, M. S. Search for Related Content PubMed PubMed Citation Articles by Thaete, L. G. Articles by Neerhof, M. G. Articles by Jilling, T. Articles by Caplan, M. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Risk Pregnancy Social Bookmarking                         What's this?

Infusion of Exogenous Platelet-Activating Factor Produces Intrauterine Growth Restriction in the Rat

Departments of Obstetrics and Gynecology and Pediatrics, Evanston Northwestern Healthcare, Evanston, Illinois; Evanston Northwestern Healthcare, 2560 Ridge Avenue, Suite 1600 WH, Evanston, IL 60201; lthaete{at}enh.org

Mark G. Neerhof, DO

Tamas Jilling, MD

Michael S. Caplan, MD

Departments of Obstetrics and Gynecology and Pediatrics, Evanston Northwestern Healthcare, Evanston, Illinois

Objective: To determine the impact of exogenous platelet-activating factor (PAF) on pregnancy outcome in th rat.

Methods: Carbamyl-PAF (0.05, 0.5, or 5.0 µg/kg per hour) or vehicle was infused intravenously for 7 days by osmotic pump into timed pregnant rats. Infusion was begun on day 14 of a 22-day gestation. Maternal mean arterial blood pressures were measured on days 1, 4, and 7 of the infusion. On gestational day 21 (PAF infusion day 7), fetal and placental weights and viability were evaluated at hysterotomy. Uterine and placental PAF receptor expression was analyzed by reverse transcription-polymerase chain reaction and agarose gel electrophoresis. Data were analyzed by analyzis of variance, ², or the Mann-Whitney U test as appropriate.

Results: Fetal weights were dose-dependently lower than control, by 19% and 35%, respectively, at dosages of 0.5 and 5.0 µg/kg per hour (P < .001) but were not affected at the 0.05 µg/kg per hour dose of carbamyl-PAF. Placental weights were significantly lower at all doses (P < .001). Fetal demise was dose-dependently higher and was significantly different from the control group at the 0.5 and 5.0 µg/kg per hour doses of carbamyl-PAF (P < .0001). Maternal mean arterial pressures were not altered by these doses of carbamyl-PAF. PAF receptors were expressed abundantly in both uterus and placenta.

Conclusion: Exogenous PAF produces dose-dependent fetal growth restriction in the rat. Placental growth is particularly sensitive to PAF and, coupled with the dose-dependent decline in fetal growth, suggests a dose-dependent decline in function. An elevated level of PAF is detrimental to fetal growth and well-being in the rat.

Key Words: Platelet-activating factor • intrauterine growth restriction • rat • pregnancy

Journal of the Society for Gynecologic Investigation, Vol. 10, No. 3, 145-150 (2003)
DOI: 10.1016/S1071-55760300005-4


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?